These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20091246)

  • 1. S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.
    Nath N; Morinaga O; Singh I
    J Neuroimmune Pharmacol; 2010 Jun; 5(2):240-51. PubMed ID: 20091246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione.
    Singh I; Nath N; Saxena N; Singh AK; Won JS
    Immunobiology; 2018 Oct; 223(10):549-554. PubMed ID: 29960806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
    J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
    Saxena N; Won J; Choi S; Singh AK; Singh I
    Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism.
    Sloka S; Silva C; Wang J; Yong VW
    J Neuroinflammation; 2011 May; 8():56. PubMed ID: 21605467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
    Prasad R; Giri S; Nath N; Singh I; Singh AK
    Glia; 2007 Jan; 55(1):65-77. PubMed ID: 17019693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
    Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
    Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
    J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
    Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
    J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
    Nath N; Giri S; Prasad R; Singh AK; Singh I
    J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
    Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
    J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
    Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology.
    van Hamburg JP; de Bruijn MJ; Ribeiro de Almeida C; van Zwam M; van Meurs M; de Haas E; Boon L; Samsom JN; Hendriks RW
    Eur J Immunol; 2008 Sep; 38(9):2573-86. PubMed ID: 18792410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1/Th17 and expansion of Th2/Treg responses.
    Zargarani S; Tavaf MJ; Soltanmohammadi A; Yazdanpanah E; Baharlou R; Yousefi B; Sadighimoghaddam B; Esmaeili SA; Haghmorad D
    Cell Biol Int; 2024 Aug; 48(8):1124-1137. PubMed ID: 38741520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
    Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daphnetin alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating Th2 and regulatory T cells.
    Soltanmohammadi A; Tavaf MJ; Zargarani S; Yazdanpanah E; Sadighi-Moghaddam B; Yousefi B; Sameni HR; Haghmorad D
    Acta Neurobiol Exp (Wars); 2022; 82(3):273-283. PubMed ID: 36214710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
    Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.